These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 17451346)

  • 1. Molecular epidemiology of HIV type 1 in treatment-naive patients in north Ethiopia.
    Kassu A; Fujino M; Matsuda M; Nishizawa M; Ota F; Sugiura W
    AIDS Res Hum Retroviruses; 2007 Apr; 23(4):564-8. PubMed ID: 17451346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV-1 pol phylogenetic diversity and antiretroviral resistance mutations in treatment naïve patients from Central West Brazil.
    Cardoso LP; Queiroz BB; Stefani MM
    J Clin Virol; 2009 Oct; 46(2):134-9. PubMed ID: 19682948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of drug-resistance-associated mutations in antiretroviral drug-naive Zambians infected with subtype C HIV-1.
    Handema R; Terunuma H; Kasolo F; Kasai H; Sichone M; Yamashita A; Deng X; Mulundu G; Ichiyama K; Munkanta M; Yokota T; Wakasugi N; Tezuka F; Yamamoto N; Ito M
    AIDS Res Hum Retroviruses; 2003 Feb; 19(2):151-60. PubMed ID: 12643279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Limited increase in primary HIV-1C drug resistance mutations in treatment naïve individuals in Ethiopia.
    Huruy K; Maier M; Mulu A; Liebert UG
    J Med Virol; 2015 Jun; 87(6):978-84. PubMed ID: 25649964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV type 1 drug resistance among naive patients from Venezuela.
    Bouchard M; Masquelier B; Moreno M; Deibis L; De Pérez GE; Fleury H; Castro E
    AIDS Res Hum Retroviruses; 2007 Mar; 23(3):482-5. PubMed ID: 17411383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequency of protease and reverse transcriptase drug resistance mutations in naïve HIV-infected patients.
    Valle-Bahena OM; Ramos-Jiménez J; Ortiz-López R; Revol A; Lugo-Trampe A; Barrera-Saldaña HA; Rojas-Martínez A
    Arch Med Res; 2006 Nov; 37(8):1022-7. PubMed ID: 17045121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human immunodeficiency virus type 1 drug resistance mutations in peripheral blood mononuclear cell proviral DNA among antiretroviral treatment-naive and treatment-experienced patients from Pune, India.
    Sen S; Tripathy SP; Chimanpure VM; Patil AA; Bagul RD; Paranjape RS
    AIDS Res Hum Retroviruses; 2007 Apr; 23(4):489-97. PubMed ID: 17506605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiretroviral drug resistance and HIV-1 subtypes among treatment-naive prisoners in Kelantan, Malaysia.
    Ariffin TA; Mohamad S; Yusuf WN; Shueb RH
    J Infect Dev Ctries; 2014 Aug; 8(8):1063-7. PubMed ID: 25116676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic diversity and drug resistance mutations in HIV type 1 from untreated patients in Bamako, Mali.
    Derache A; Traore O; Koita V; Sylla A; Tubiana R; Simon A; Canestri A; Carcelain G; Katlama C; Calvez V; Cisse M; Marcelin AG
    Antivir Ther; 2007; 12(1):123-9. PubMed ID: 17503757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genotypic analysis of the protease and reverse transcriptase of HIV type 1 subtype C isolates from antiretroviral drug-naive adults in Malawi.
    Petch LA; Hoffman IF; Jere CS; Kazembe PN; Martinson FE; Chilongozi D; Fiscus SA; Cohen MS
    AIDS Res Hum Retroviruses; 2005 Sep; 21(9):799-805. PubMed ID: 16218804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations in the reverse transcriptase and protease genes of human immunodeficiency virus-1 from antiretroviral naïve and treated pediatric patients.
    Bure D; Makhdoomi MA; Lodha R; Prakash SS; Kumar R; Parray HA; Singh R; Kabra SK; Luthra K
    Viruses; 2015 Feb; 7(2):590-603. PubMed ID: 25674767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genotypic resistance to antiretroviral drugs in patients infected with several HIV type 1 genetic forms in Cuba.
    Pérez L; Alvarez LP; Carmona R; Aragonés C; Delgado E; Thomson MM; González Z; Contreras G; Pérez J; Nájera R
    AIDS Res Hum Retroviruses; 2007 Mar; 23(3):407-14. PubMed ID: 17411374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Appearance of drug resistance-associated mutations in human immunodeficiency virus type 1 protease and reverse transcriptase derived from drug-treated Indonesian patients.
    Khairunisa SQ; Kotaki T; Witaningrum AM; Yunifiar M MQ; Sukartiningrum SD; Nasronudin ; Kameoka M
    AIDS Res Hum Retroviruses; 2015 Feb; 31(2):255-9. PubMed ID: 25348045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV type 1 pol gene diversity and archived nevirapine resistance mutation in pregnant women in Rwanda.
    Servais J; Lambert C; Karita E; Vanhove D; Fischer A; Baurith T; Schmit JC; Schneider F; Hemmer R; Arendt V
    AIDS Res Hum Retroviruses; 2004 Mar; 20(3):279-83. PubMed ID: 15117451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV type 1 genotypic variation in an antiretroviral treatment-naive population in southern India.
    Balakrishnan P; Kumarasamy N; Kantor R; Solomon S; Vidya S; Mayer KH; Newstein M; Thyagarajan SP; Katzenstein D; Ramratnam B
    AIDS Res Hum Retroviruses; 2005 Apr; 21(4):301-5. PubMed ID: 15943572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of HIV-1 isolates from antiretroviral drug-naive children in southern India.
    Soundararajan L; Karunaianandham R; Jauvin V; Schrive MH; Ramachandran R; Narayanan PR; Fleury HJ; Swaminathan S
    AIDS Res Hum Retroviruses; 2007 Sep; 23(9):1119-26. PubMed ID: 17919107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of transmitted HIV drug resistance in Iran between 2010 and 2011.
    Jahanbakhsh F; Hattori J; Matsuda M; Ibe S; Monavari SH; Memarnejadian A; Aghasadeghi MR; Mostafavi E; Mohraz M; Jabbari H; Kamali K; Keyvani H; Azadmanesh K; Sugiura W
    PLoS One; 2013; 8(4):e61864. PubMed ID: 23626742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resistance mutational analysis of HIV type 1 subtype C among rural South African drug-naive patients prior to large-scale availability of antiretrovirals.
    Bessong PO; Mphahlele J; Choge IA; Obi LC; Morris L; Hammarskjold ML; Rekosh DM
    AIDS Res Hum Retroviruses; 2006 Dec; 22(12):1306-12. PubMed ID: 17209775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular characterization of HIV type 1 in Brazzaville, Republic of Congo, and first data on resistance to antiretroviral drugs.
    Pircher M; Diafouka M; Papuchon J; Recordon-Pinson P; Mahambou DN; Akolbout M; Simon B; Fleury H
    AIDS Res Hum Retroviruses; 2012 Dec; 28(12):1798-802. PubMed ID: 22697883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The molecular epidemiology and drug resistance determination of HIV type 1 subtype B infection in Barbados.
    Gittens MV; Roth WW; Roach T; Stringer HG; Pieniazek D; Bond VC; Levett PN
    AIDS Res Hum Retroviruses; 2003 Apr; 19(4):313-9. PubMed ID: 12816080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.